Objectives To review the current evidence on the relationship between agents that affect
bone homeostasis and dental implant failures. Materials and Methods Electronic searches …

Bone-modifying agents (BMAs) are integral to managing patients with advanced cancer.
They improve quality of survival by reducing skeletal-related events, treating …

Background. Medication‐related osteonecrosis of the jaw (MRONJ) is a serious adverse
drug reaction characterized by progressive bone destruction and necrosis of mandibular …

The use of antiangiogenic and antiresorptive medications, particularly in patients with
cancer or osteoporosis, can lead to osteonecrosis of the jaw following tooth extraction …

This case report aims to highlight the importance of close oral monitoring before and during
chemotherapy in patients with B-cell acute lymphoblastic leukemia (B-ALL) to prevent …

Background. Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse
drug reaction characterized by progressive bone destruction and necrosis of mandibular …

Medication-related osteonecrosis of the jaw (MRONJ) is a side effect in patients taking bone-
modifying agents (BMAs), which are highly beneficial for treating osteoporosis and cancer …

(MRONJ) guidance was published in 2017 as an update of the 2011 SDCEP publication
Oral Health Management of Patients Prescribed Bisphosphonates. The guidance topic was …

Introdução: A osteonecrose dos maxilares induzida por medicamentos (OMM) é definida
como exposição de osso na região maxilomandibular por mais de oito semanas em …